Literature DB >> 25469340

Subclinical hypothyroidism diagnosed by thyrotropin-releasing hormone stimulation test in infertile women with basal thyroid-stimulating hormone levels of 2.5 to 5.0 mIU/L.

You-Jeong Lee1, Chung-Hoon Kim1, Jae-Young Kwack1, Jun-Woo Ahn2, Sung-Hoon Kim1, Hee-Dong Chae1, Byung-Moon Kang1.   

Abstract

OBJECTIVE: To investigate the prevalence of subclinical hypothyroidism (SH) diagnosed by thyrotropin-releasing hormone (TRH) stimulating test in infertile women with basal thyroid-stimulating hormone (TSH) levels of 2.5 to 5.0 mIU/L.
METHODS: This study was performed in 39 infertile women with ovulatory disorders (group 1) and 27 infertile women with male infertility only (group 2, controls) who had basal serum TSH levels of 2.5 to 5.0 mIU/L and a TRH stimulating test. Serum TSH levels were measured before TRH injection (TSH0) and also measured at 20 minutes (TSH1) and 40 minutes (TSH2) following intravenous injection of 400 µg TRH. Exaggerated TSH response above 30 mIU/L following TRH injection was diagnosed as SH. Group 1 was composed of poor responders (subgroup A), patients with polycystic ovary syndrome (subgroup B) and patients with WHO group II anovulation except poor responder or polycystic ovary syndrome (subgroup C).
RESULTS: The prevalence of SH was significantly higher in group 1 of 46.2% (18/39) compared with 7.4% (2/27) in group 2 (P=0.001). TSH0, TSH1, and TSH2 levels were significantly higher in group 1 than the corresponding values in group 2 (P<0.001, P<0.001, P<0.001). In group 1, TSH1 and TSH2 levels were significantly lower in subgroup C compared with those in subgroup A and B (P=0.008, P=0.006, respectively).
CONCLUSION: TRH stimulation test had better be performed in infertile women with ovulatory disorders who have TSH levels between 2.5 and 5.0 mIU/L for early detection and appropriate treatment of SH.

Entities:  

Keywords:  Infertility; Ovulatory disorder; Subclinical hypothyroidism; Thyrotropin-releasing hormone stimulating test

Year:  2014        PMID: 25469340      PMCID: PMC4245345          DOI: 10.5468/ogs.2014.57.6.507

Source DB:  PubMed          Journal:  Obstet Gynecol Sci        ISSN: 2287-8572


  17 in total

Review 1.  Serum thyroid-stimulating hormone measurement for assessment of thyroid function and disease.

Authors:  D S Ross
Journal:  Endocrinol Metab Clin North Am       Date:  2001-06       Impact factor: 4.741

2.  Episodic variations of prolactin, thyroid-stimulating hormone, luteinizing hormone, melatonin and cortisol in infertile women with subclinical hypothyroidism.

Authors:  M Bals-Pratsch; C De Geyter; T Müller; U Frieling; A Lerchl; K M Pirke; J P Hanker; C Becker-Carus; E Nieschlag
Journal:  Hum Reprod       Date:  1997-05       Impact factor: 6.918

3.  ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria.

Authors:  A P Ferraretti; A La Marca; B C J M Fauser; B Tarlatzis; G Nargund; L Gianaroli
Journal:  Hum Reprod       Date:  2011-04-19       Impact factor: 6.918

Review 4.  Subclinical thyroid disease: scientific review and guidelines for diagnosis and management.

Authors:  Martin I Surks; Eduardo Ortiz; Gilbert H Daniels; Clark T Sawin; Nananda F Col; Rhoda H Cobin; Jayne A Franklyn; Jerome M Hershman; Kenneth D Burman; Margo A Denke; Colum Gorman; Richard S Cooper; Neil J Weissman
Journal:  JAMA       Date:  2004-01-14       Impact factor: 56.272

5.  Subclinical thyroid disease: clinical applications.

Authors:  Nananda F Col; Martin I Surks; Gilbert H Daniels
Journal:  JAMA       Date:  2004-01-14       Impact factor: 56.272

6.  Influence of antithyroid antibodies in euthyroid women on in vitro fertilization-embryo transfer outcome.

Authors:  C H Kim; H D Chae; B M Kang; Y S Chang
Journal:  Am J Reprod Immunol       Date:  1998-07       Impact factor: 3.886

Review 7.  The role of thyroid autoimmunity in fertility and pregnancy.

Authors:  Kris Poppe; Brigitte Velkeniers; Daniel Glinoer
Journal:  Nat Clin Pract Endocrinol Metab       Date:  2008-05-27

8.  Subclinical hypothyroidism and thyroid autoimmunity in women with infertility.

Authors:  Marcos Abalovich; Laura Mitelberg; Carlos Allami; Silvia Gutierrez; Graciela Alcaraz; Patricia Otero; Oscar Levalle
Journal:  Gynecol Endocrinol       Date:  2007-05       Impact factor: 2.260

9.  Subclinical hypothyroidism in infertile women: the importance of continuous monitoring and the role of the thyrotropin-releasing hormone stimulation test.

Authors:  Talia Eldar-Geva; Michal Shoham; Ariel Rösler; Ehud J Margalioth; Keren Livne; Dror Meirow
Journal:  Gynecol Endocrinol       Date:  2007-06       Impact factor: 2.260

10.  Prevalence of hypothyroidism in infertile women and evaluation of response of treatment for hypothyroidism on infertility.

Authors:  Indu Verma; Renuka Sood; Sunil Juneja; Satinder Kaur
Journal:  Int J Appl Basic Med Res       Date:  2012-01
View more
  2 in total

1.  Thyroid-Stimulating Hormone Values in Pregnancy: Cutoff Controversy Continues?

Authors:  Suvarna Khadilkar
Journal:  J Obstet Gynaecol India       Date:  2019-09-13

2.  Gestational Age-specific Cut-off Values Are Needed for Diagnosis of Subclinical Hypothyroidism in Early Pregnancy.

Authors:  Hye Sung Kim; Byoung Jae Kim; Sohee Oh; Da Young Lee; Kyu Ri Hwang; Hye Won Jeon; Seung Mi Lee
Journal:  J Korean Med Sci       Date:  2015-08-13       Impact factor: 2.153

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.